Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
Condition: Intervention: Drug: Everolimus Sponsor: The University of Texas Health Science Center at San Antonio Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2018 Category: Research Source Type: clinical trials
